The CDK6-c-Jun-Sp1-MMP-2 Axis As a Biomarker and Therapeutic Target for Triple-Negative Breast Cancer.

Chi-Wen Luo,Ming-Feng Hou,Chia-Wei Huang,Chun-Chieh Wu,Fu Ou-Yang,Qiao-Lin Li,Cheng-Che Wu,Mei-Ren Pan

American journal of cancer research（2020）

Cited 7|Views15
No score
Key words
CDK6,MMP2,c-Jun,tumor microenvironment,sorafenib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined